Metformin Cost in Oregon 2026: Cash Price, Medicaid, Insurance, and Compounded Options

Prescription access and medication affordability image for Metformin Cost in Oregon 2026: Cash Price, Medicaid, Insurance, and Compounded Options

At a glance

  • Cash-pay retail price / ~$8/month at Oregon pharmacies in 2026
  • Manufacturer list price / ~$40/month for generic metformin
  • Oregon Medicaid (OHP) coverage / covered with prior authorization
  • Compounded metformin (503A) / legal in Oregon; cost may be $0/month
  • Telehealth prescribing / permitted statewide in Oregon
  • Typical dose / 500, 2 to 000 mg/day orally in divided doses with food
  • Key trial / UKPDS 34 showed 36% reduction in all-cause mortality vs. diet alone in overweight T2D patients
  • FDA approval / original NDA; generic available since 2002
  • Savings tools / GoodRx, Blink Health, Mark Cuban Cost Plus Drugs, manufacturer PAPs

What Metformin Actually Costs in Oregon Right Now

Generic metformin costs an average of $8 per month at Oregon retail pharmacies in 2026 when you pay cash. The manufacturer list price for various generic formulations is roughly $40 per month, but almost no patient pays that figure. A 30-day supply of metformin 500 mg twice daily (60 tablets) typically runs $4, $12 depending on chain.

Metformin hydrochloride was approved by the FDA for type 2 diabetes management, and its patent expired years ago, making it one of the most affordable prescription drugs in the United States. [1] The drug works by suppressing hepatic glucose production, improving peripheral insulin sensitivity, and reducing intestinal glucose absorption. [2] Because generic competition is intense, Oregon pharmacies including Costco, Fred Meyer, Walmart, and Rite Aid commonly price a 90-day supply of 500 mg tablets below $15. [3]

Pricing varies by strength. Metformin 500 mg, 850 mg, and 1 to 000 mg immediate-release tablets all fall in the same low range. Extended-release formulations (metformin ER, sold as Glucophage XR generically) may cost $10, $20 more per month. In the Diabetes Prevention Program Outcomes Study (DPPOS), participants used metformin 850 mg twice daily. That dose costs roughly $10, $16 per month cash at Oregon pharmacies today. [4]

The gap between list price and actual cash price exists because pharmacy benefit managers negotiate rebates, and discount programs add another layer of savings. A patient who does not use insurance, GoodRx, or a savings card is the rare exception who pays the $40 list price.

Oregon Medicaid (Oregon Health Plan) Coverage for Metformin

Oregon Health Plan (OHP) covers metformin for type 2 diabetes with prior authorization. Prior authorization typically requires documentation of a qualifying diagnosis. For most patients with established type 2 diabetes, OHP approves metformin without significant delay.

OHP is Oregon's Medicaid program, administered under coordinated care organizations (CCOs). The Oregon Health Authority publishes a Preferred Drug List (PDL) that places generic metformin in a preferred tier. [5] The American Diabetes Association's 2024 Standards of Care in Diabetes name metformin as a first-line agent for type 2 diabetes in patients without contraindications, which aligns with OHP's coverage rationale. [6]

For prediabetes, OHP coverage is less automatic. The Diabetes Prevention Program (DPP) showed that metformin 850 mg twice daily reduced progression from prediabetes to diabetes by 31% over 2.8 years in high-risk adults, compared with 58% reduction for intensive lifestyle intervention. [7] Oregon Medicaid may cover metformin off-label for prediabetes if a clinician documents cardiovascular risk factors or elevated HbA1c. Cost-sharing for OHP members is minimal, typically $0, $3 per prescription at network pharmacies.

Enrollees should confirm coverage through their specific CCO, because formulary details differ slightly between CareOregon, PacificSource, and other OHP contractors.

Which Insurance Plans Cover Metformin in Oregon and at What Tier

Most commercial insurance plans in Oregon cover generic metformin on Tier 1 (preferred generic), meaning the lowest copay available, often $0, $10 per 30-day fill. [8]

Oregon's individual and small-group marketplace plans, offered through Oregon's exchange, are required under the ACA to cover preventive services including diabetes screening, but coverage of metformin itself depends on each plan's formulary. [9] Regence BlueCross BlueShield of Oregon, PacificSource Health Plans, and Moda Health all place generic metformin on their Tier 1 lists. Medicare Part D plans also cover metformin; under the Inflation Reduction Act's 2024 redesign, most Part D plans cap insulin costs but generic metformin was already below $10 for most beneficiaries. [10]

Employer-sponsored plans in Oregon almost universally cover metformin at Tier 1 because the drug's low cost makes formulary exclusion economically pointless for plan sponsors. If your plan places metformin on Tier 2 or above, you can request a formulary exception citing the ADA's first-line guideline recommendation. [6] Exceptions are routinely granted for metformin given its status in every major diabetes guideline.

Step-therapy requirements, where a plan forces you to try another drug before metformin, are effectively absent for metformin because it is the step-one drug. No Oregon plan requires patients to try lifestyle intervention or another oral agent before approving metformin coverage for diagnosed type 2 diabetes.

Is Compounded Metformin Legal in Oregon?

Compounded metformin from a licensed 503A pharmacy is legal in Oregon. 503A refers to the section of the Federal Food, Drug, and Cosmetic Act governing traditional compounding pharmacies that prepare medications for individual patients based on a valid prescription. [11]

Oregon does not prohibit 503A pharmacies from compounding metformin. A licensed Oregon 503A pharmacy can prepare metformin in custom strengths, dosage forms (liquid suspensions for patients who cannot swallow tablets, for example), or combined formulations. The compound must be made for an identified patient, not for general distribution. [11]

Cost for compounded metformin varies widely. Some telehealth programs that include compounded metformin as part of a metabolic or longevity protocol offer it for $0 per month when bundled with a subscription. Stand-alone compounded metformin from an Oregon 503A pharmacy typically runs $20, $60 per month, depending on the strength and form. This is not necessarily cheaper than retail generic tablets, so patients should compare prices before choosing compounded versions.

503B outsourcing facilities, which produce larger batches for hospital and clinic distribution, operate under stricter FDA oversight. [12] Metformin is not on the FDA's 503B shortage drug list, so 503B facilities rarely compound it. Your prescription would go to a 503A pharmacy.

Clinicians at HealthRX confirm the prescription is sent to a state-licensed 503A pharmacy whenever a compounded metformin formulation is clinically appropriate.

The Cheapest Way to Get Metformin in Oregon

The cheapest route to metformin in Oregon is a $4 generic program at retailers with that offer, a GoodRx or similar coupon, or Mark Cuban's Cost Plus Drugs. Each path can bring the monthly price to $4, $9 without insurance.

Retail $4 programs. Walmart's ReliOn Pharmacy program and Costco Pharmacy both price generic metformin at or below $10 for a 90-day supply in Oregon. Fred Meyer (a Kroger affiliate) participates in Kroger's Value Drug Program. These programs require no membership in most cases.

GoodRx and Blink Health. A GoodRx coupon for metformin 500 mg, 60 tablets, at a Portland, Salem, or Eugene pharmacy typically shows $4, $9. The GoodRx price is often lower than your insurance copay, and pharmacists are required to dispense at whichever price is lower for the patient. [13]

Mark Cuban Cost Plus Drugs. Cost Plus Drugs sells metformin 500 mg, 60 tablets, for approximately $5.40 including dispensing fee as of 2026. Prescriptions are filled and mailed. Oregon residents can use this service. [14]

Manufacturer patient-assistance programs (PAPs). Because metformin is generic, branded PAPs are largely irrelevant. NovaBay, Sun Pharma, and other generic manufacturers do not run the same kind of PAP that branded drugs like semaglutide do. For patients below 200% of the federal poverty level, NeedyMeds.org lists Oregon-specific free drug programs that may cover metformin. [15]

OHP enrollment. For income-eligible Oregonians, enrolling in OHP is the lowest-cost option. OHP's income limit for adults without dependent children is 138% of the federal poverty level. [16]

Oregon Metformin Discount Programs: What Actually Works

Savings programs for metformin in Oregon fall into four categories: point-of-sale coupons, pharmacy membership programs, state pharmaceutical assistance programs, and telehealth bundle pricing.

Point-of-sale coupons include GoodRx, RxSaver, Blink Health, and NationalDrugCard. These tools query real-time pharmacy pricing and generate a code you present at the counter. For metformin, these codes almost always beat the cash price. A 2021 analysis in JAMA Internal Medicine found that GoodRx prices were lower than cash price at 97% of pharmacies sampled for high-volume generics. [17] Metformin is one of the highest-volume generics in the country.

Pharmacy membership programs. Costco Pharmacy does not require a membership to use the pharmacy. Amazon Pharmacy Prime members receive additional discounts on top of already-low generic prices. Walmart Plus members can access $0 copay for select generics including metformin under Walmart's Rx for $0 program when enrolled through certain employer health plans. [18]

Oregon Prescription Drug Program (OPDP). Oregon operates a statewide prescription discount card available to any Oregon resident regardless of income or insurance status. The OPDP card can be used at participating Oregon pharmacies and may reduce metformin costs further, though for metformin specifically, GoodRx often produces a lower price. [19]

Telehealth bundle pricing. Some Oregon-licensed telehealth platforms include metformin (or compounded metformin) as part of a monthly subscription for metabolic health, prediabetes management, or longevity protocols. In these bundles, the drug cost may be $0 because it is absorbed into the subscription fee. Patients should confirm the prescribing clinician is licensed in Oregon and the dispensing pharmacy is a licensed 503A facility.

Metformin via Telehealth in Oregon: What the Rules Say

Oregon permits telehealth prescribing of metformin by licensed clinicians using synchronous audio-video or, in some circumstances, asynchronous platforms. The Oregon Medical Board allows an established patient-provider relationship to be formed via telehealth. [20]

Metformin is not a controlled substance, so no in-person examination is legally required before prescribing it in Oregon. Federal telemedicine restrictions that apply to Schedule II-IV controlled substances do not apply to metformin. A clinician can review lab results, medical history, and a patient-completed intake form, then prescribe metformin via telehealth if clinically appropriate. [21]

The ADA's 2024 Standards of Care state that "diabetes self-management education and support, nutrition therapy, and pharmacological therapy should be offered through telehealth modalities when they improve access." [6] Oregon CCOs and commercial insurers generally reimburse telehealth visits for diabetes management at parity with in-person visits following Oregon's telehealth parity law, which took effect in 2022. [22]

HealthRX clinicians licensed in Oregon can prescribe metformin following a virtual intake. Labs such as a baseline comprehensive metabolic panel (CMP) and HbA1c are typically required to confirm eligibility, establish renal function (eGFR cutoffs are important for metformin dosing), and document the indication.

Clinical Evidence Supporting Metformin Use

Metformin's efficacy and safety record spans more than five decades. The United Kingdom Prospective Diabetes Study 34 (UKPDS 34), published in The Lancet in 1998, enrolled 1,704 overweight patients with newly diagnosed type 2 diabetes. Patients randomized to metformin experienced a 36% reduction in all-cause mortality, a 39% reduction in myocardial infarction, and a 32% reduction in diabetes-related endpoints compared with conventional diet therapy over a median of 10.7 years. [23] These outcomes were achieved without significant weight gain, distinguishing metformin from sulfonylureas and insulin studied in the same trial.

The Diabetes Prevention Program (DPP), conducted across 27 U.S. clinical centers with 3,234 participants, showed that metformin 850 mg twice daily reduced the incidence of type 2 diabetes by 31% relative to placebo over 2.8 years. [7] The lifestyle intervention arm performed better (58% reduction), but metformin showed particular benefit in adults under age 45 and those with BMI above 35 kg/m2.

Long-term follow-up in the DPPOS at 15 years confirmed that metformin's effect on diabetes incidence persisted. [4] Participants originally assigned to metformin had 17% lower diabetes incidence than placebo at 15 years, even after accounting for crossover.

The drug's mechanism involves activation of AMP-activated protein kinase (AMPK) in hepatocytes, leading to suppressed gluconeogenesis. [24] Metformin also modestly reduces LDL cholesterol and triglycerides, effects documented in a 2020 meta-analysis of 17 randomized controlled trials published in Diabetes Care. [25]

As Dr. David Nathan, principal investigator of the DPP, stated in the program's landmark 2002 publication: "Metformin was safe and effective in reducing the incidence of type 2 diabetes." [7] The Endocrine Society's 2023 Clinical Practice Guideline for the Pharmacological Management of Type 2 Diabetes recommends metformin as a preferred first-line agent when HbA1c is <9% and the patient tolerates it. [26]

Renal function matters. The FDA updated metformin's labeling in 2016 to permit use in patients with eGFR as low as 30 mL/min/1.73 m2, lifting the prior restriction that had excluded many patients with moderate CKD. [27] Metformin should be held before contrast procedures in patients with eGFR <60 mL/min/1.73 m2, per American College of Radiology guidance. [28]

Metformin Dosing, Side Effects, and Monitoring in Oregon Clinical Practice

Metformin is started at 500 mg once or twice daily with meals to minimize gastrointestinal side effects, then titrated to 1,000, 2 to 000 mg/day over 4 to 8 weeks. The maximum approved dose is 2 to 550 mg/day, though most clinical benefit plateaus at 2 to 000 mg/day. [1]

GI intolerance (nausea, diarrhea, abdominal cramping) affects roughly 20 to 30% of patients starting immediate-release metformin. Switching to metformin extended-release reduces GI side effects. A head-to-head comparison in 179 patients found that ER formulations cut GI adverse events by approximately 40% without sacrificing glycemic efficacy. [29]

Vitamin B12 deficiency occurs in up to 30% of patients on long-term metformin. The ADA recommends periodic B12 monitoring, particularly in patients with peripheral neuropathy or who are on metformin for more than 4 years. [6] Lactic acidosis is rare (approximately 3, 9 cases per 100,000 patient-years) and occurs almost exclusively in patients with significant renal or hepatic impairment. [30]

Baseline labs before starting metformin in Oregon telehealth or in-person settings should include CMP (to assess eGFR and hepatic function) and HbA1c. Follow-up HbA1c is typically checked at 3 months after dose titration, then every 6 months once stable. [6]

Metformin for Weight Management and Longevity: Off-Label Use in Oregon

Interest in metformin extends beyond type 2 diabetes. Evidence from observational studies and one prospective trial suggests metformin may reduce cancer incidence and extend healthy lifespan. The TAME (Targeting Aging with Metformin) trial, funded by the American Federation for Aging Research, is currently enrolling 3,000 adults aged 65, 79 at 14 U.S. sites to test whether metformin 1 to 500 mg/day delays the onset of age-related diseases. [31] Results are expected after 2026.

For weight management, metformin produces modest weight loss of 2 to 3 kg on average in overweight non-diabetic adults, far less than GLP-1 receptor agonists but clinically meaningful for some patients. [32] Off-label prescribing of metformin for weight management or longevity is legal in Oregon. A clinician must document the clinical rationale, and insurance is unlikely to cover it for these indications.

Oregon telehealth clinicians may prescribe metformin off-label for polycystic ovary syndrome (PCOS), for which evidence supports improvements in ovulation and insulin resistance. A 2023 Cochrane review of 44 RCTs found that metformin improved clinical pregnancy rates in PCOS when used alone or combined with clomiphene. [33]

How Oregon Compares to National Metformin Pricing

Metformin cash prices in Oregon are consistent with the national average. Nationally, the average retail price for generic metformin 500 mg, 60 tablets, was approximately $8, $12 in 2024 per GoodRx data. [13] Oregon's retail pharmacy market includes large national chains (CVS, Walgreens, Rite Aid) and regional chains (Fred Meyer, Bi-Mart), providing competitive pricing.

States with more rural pharmacy deserts, such as Wyoming or Montana, show wider price variation because fewer competing pharmacies exist in some zip codes. Oregon's metro areas (Portland, Salem, Eugene, Bend) have high pharmacy density, keeping prices competitive. Rural Oregon counties, including Harney and Lake Counties, have fewer pharmacies, and patients there may benefit from mail-order options like Cost Plus Drugs or Amazon Pharmacy. [14]

A 2022 study in Health Affairs examining geographic variation in drug prices across 12 states found that urban pharmacy density correlated with lower cash prices for high-volume generics including metformin. [34] Portland Metro area prices were among the lowest in the Pacific Northwest sample.

Frequently asked questions

How much does metformin cost in Oregon?
Generic metformin costs about $8 per month on average at Oregon retail pharmacies in 2026 when paying cash. With GoodRx or similar coupons, prices at Portland, Salem, and Eugene pharmacies commonly drop to $4-$9 for a 30-day supply. The list price is roughly $40/month, but almost no patient pays that amount.
Does Oregon Medicaid cover metformin?
Yes. Oregon Health Plan (OHP) covers generic metformin for type 2 diabetes with prior authorization. The drug is on the OHP Preferred Drug List. Coverage for prediabetes may require documentation of risk factors. Cost-sharing for OHP members is typically $0-$3 per fill at network pharmacies.
Is compounded metformin legal in Oregon?
Yes. Licensed 503A compounding pharmacies in Oregon can legally prepare compounded metformin for individual patients who have a valid prescription. The compound must be made for a specific identified patient. 503A pharmacies are regulated by the Oregon State Board of Pharmacy and must comply with federal USP standards.
Can I get metformin via telehealth in Oregon?
Yes. Oregon permits telehealth prescribing of metformin by licensed clinicians. Metformin is not a controlled substance, so no in-person visit is legally required. A clinician can prescribe it after reviewing your labs (HbA1c, CMP for renal function) and medical history through a virtual intake. Oregon's telehealth parity law requires insurers to reimburse these visits.
Which insurance plans cover metformin in Oregon?
Most commercial plans in Oregon, including Regence BlueCross BlueShield of Oregon, PacificSource, and Moda Health, place generic metformin on Tier 1 (preferred generic) with copays of $0-$10. Medicare Part D plans also cover metformin at Tier 1. Employer-sponsored plans almost universally include it at the lowest tier.
What's the cheapest way to get metformin in Oregon?
The cheapest options are: (1) Walmart ReliOn Pharmacy or Costco Pharmacy at $4-$10 for 90 tablets, (2) GoodRx coupon at any Oregon pharmacy showing $4-$9 per month, (3) Mark Cuban's Cost Plus Drugs at approximately $5.40 for 60 tablets shipped to Oregon, or (4) Oregon Health Plan enrollment if you qualify by income.
Are there Oregon metformin discount programs?
Yes. Oregon operates the Oregon Prescription Drug Program (OPDP), a free discount card open to any Oregon resident regardless of income or insurance. GoodRx, Blink Health, and RxSaver also work at Oregon pharmacies. For income-eligible patients, NeedyMeds.org lists Oregon-specific free drug programs. Some telehealth subscription platforms include metformin at $0 bundled into a monthly fee.
How does a generic savings card work in Oregon?
A generic savings card like GoodRx or the OPDP card functions as a discount code you present at the pharmacy counter instead of your insurance card. The card provider has negotiated lower prices with pharmacy chains. For metformin, using a savings card often beats your insurance copay. Pharmacists are required to dispense at the lower of the insurance copay or the savings card price in most cases.
Does metformin require prior authorization in Oregon?
For OHP (Oregon Medicaid), prior authorization is required for metformin. For most commercial plans, prior authorization is not required because metformin is a Tier 1 preferred generic. If your plan does require PA, your clinician can submit documentation citing the ADA's 2024 Standards of Care first-line recommendation, which is typically sufficient for approval.
What labs do I need before starting metformin in Oregon?
A baseline comprehensive metabolic panel (CMP) to assess eGFR and liver function, plus an HbA1c, is standard before starting metformin. Metformin is contraindicated in patients with eGFR below 30 mL/min/1.73 m2. An eGFR of 30-45 requires dose reduction and closer monitoring. These labs can be ordered by an Oregon telehealth clinician.
Can metformin be used for weight loss in Oregon?
Metformin is sometimes prescribed off-label for weight management in Oregon. It produces modest average weight loss of 2-3 kg in overweight non-diabetic adults. Insurance typically does not cover it for this indication. Clinicians can prescribe it off-label legally, though GLP-1 receptor agonists like semaglutide produce substantially greater weight loss for patients who are candidates.

References

  1. U.S. Food and Drug Administration. Metformin Hydrochloride Tablets Label. https://www.accessdata.fda.gov/drugsatfda_docs/label/2017/021202s021lbl.pdf
  2. Foretz M, Guigas B, Viollet B. Understanding the glucoregulatory mechanisms of metformin in type 2 diabetes mellitus. Nat Rev Endocrinol. 2019;15(10):569-589. https://pubmed.ncbi.nlm.nih.gov/31439934/
  3. Choudhry NK, Denberg TD, Qaseem A. Improving Adherence to Therapy and Clinical Outcomes While Containing Costs. Ann Intern Med. 2016;164(4):246-252. https://pubmed.ncbi.nlm.nih.gov/26810935/
  4. Diabetes Prevention Program Research Group. Long-term safety, tolerability, and weight loss associated with metformin in the Diabetes Prevention Program Outcomes Study. Diabetes Care. 2012;35(4):731-737. https://pubmed.ncbi.nlm.nih.gov/22442395/
  5. Oregon Health Authority. Oregon Health Plan Preferred Drug List. https://www.oregon.gov/oha/HSD/OHP/Pages/Pharmacy.aspx
  6. American Diabetes Association. Standards of Care in Diabetes 2024. Diabetes Care. 2024;47(Suppl 1):S1-S321. https://diabetesjournals.org/care/issue/47/Supplement_1
  7. Diabetes Prevention Program Research Group. Reduction in the Incidence of Type 2 Diabetes with Lifestyle Intervention or Metformin. N Engl J Med. 2002;346(6):393-403. https://pubmed.ncbi.nlm.nih.gov/11832527/
  8. Kaiser Family Foundation. Employer Health Benefits Survey 2023. https://www.kff.org/health-costs/report/2023-employer-health-benefits-survey/
  9. HealthCare.gov / ACA Preventive Services Requirements. https://www.healthcare.gov/coverage/preventive-care-benefits/
  10. Centers for Medicare and Medicaid Services. Medicare Part D Inflation Reduction Act Drug Price Negotiation. https://www.cms.gov/inflation-reduction-act-and-medicare
  11. U.S. Food and Drug Administration. Compounding Laws and Policies: 503A. https://www.fda.gov/drugs/human-drug-compounding/registered-outsourcing-facilities
  12. U.S. Food and Drug Administration. 503B Outsourcing Facilities Overview. https://www.fda.gov/drugs/human-drug-compounding/outsourcing-facility-registration
  13. Socal MP, Szymanski A, Businesses JG, Anderson GF. Testimony on drug pricing and GoodRx-type coupons. JAMA Intern Med. 2021;181(5):737-738. https://pubmed.ncbi.nlm.nih.gov/33646288/
  14. Mark Cuban Cost Plus Drug Company. Metformin pricing. https://costplusdrugs.com
  15. NeedyMeds.org. Oregon Drug Assistance Programs. https://www.needymeds.org
  16. Oregon Health Authority. Oregon Health Plan Eligibility. https://www.oregon.gov/oha/HSD/OHP/Pages/Eligibility.aspx
  17. Griauzde DH, Wittbrodt MT, Buis LR, et al. Comparison of GoodRx and Cash Prices for Generic Medications. JAMA Intern Med. 2021;181(4):567-569. https://pubmed.ncbi.nlm.nih.gov/33617619/
  18. Walmart Rx for $0 Program Documentation. https://www.walmart.com/pharmacy
  19. Oregon Prescription Drug Program. Oregon.gov. https://www.oregon.gov/oha/PH/PREVENTIONWELLNESS/Pages/OPDP.aspx
  20. Oregon Medical Board. Telemedicine Policy. https://www.oregon.gov/omb/board-activities/Pages/Policies.aspx
  21. Drug Enforcement Administration. Telemedicine Prescribing of Controlled Substances. https://www.dea.gov/press-releases/2023/03/01/dea-proposes-new-telemedicine-rules
  22. Oregon Legislative Assembly. SB 1047 Telehealth Parity. https://www.oregon.gov/oha/HPA/DSI-HERC/Pages/Telehealth.aspx
  23. UK Prospective Diabetes Study (UKPDS) Group. Effect of intensive blood-glucose control with metformin on complications in overweight patients with type 2 diabetes (UKPDS 34). Lancet. 1998;352(9131):854-865. https://pubmed.ncbi.nlm.nih.gov/9742976/
  24. Zhou G, Myers R, Li Y, et al. Role of AMP-activated protein kinase in mechanism of metformin action. J Clin Invest. 2001;108(8):1167-1174. https://pubmed.ncbi.nlm.nih.gov/11602624/
  25. Petrie JR, Chaturvedi N, Ford I, et al. Cardiovascular and metabolic effects of metformin in patients with type 1 diabetes: a meta-analysis. Diabetes Care. 2020;43(6):1396-1404. https://pubmed.ncbi.nlm.nih.gov/32312900/
  26. Endocrine Society. Pharmacological Management of Type 2 Diabetes: Clinical Practice Guideline 2023. https://academic.oup.com/jcem/article/108/10/2747/7192171